Sign In
Buy VERX
$12.91
+0.310 (+2.46%)
At Close: Jul 31, 2026
Vertex, Inc. (VERX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
02:12pm, Wednesday, 04'th Mar 2026
Vertex, Inc. (VERX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Banco Santander S.A. Lowers Stock Holdings in Vertex, Inc. $VERX
04:28am, Saturday, 28'th Feb 2026
Banco Santander S.A. lessened its holdings in shares of Vertex, Inc. (NASDAQ: VERX) by 47.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchan
Vertex to Present at Upcoming Conferences
08:00am, Friday, 27'th Feb 2026
KING OF PRUSSIA, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX), a global provider of tax technology solutions, today announced that Chris Young, President and Chief Executive Offi
Vertex (NASDAQ:VERX) Director Eric Andersen Buys 40,000 Shares of Stock
04:49am, Tuesday, 24'th Feb 2026
Vertex, Inc. (NASDAQ: VERX - Get Free Report) Director Eric Andersen bought 40,000 shares of the business's stock in a transaction dated Friday, February 20th. The stock was acquired at an average pri
Vertex (NASDAQ:VERX) Shares Gap Up After Insider Buying Activity
03:03am, Friday, 20'th Feb 2026
Vertex, Inc. (NASDAQ: VERX - Get Free Report)'s stock price gapped up prior to trading on Thursday after an insider bought additional shares in the company. The stock had previously closed at $12.09,
Why Vertex Stock Zoomed Almost 6% Higher on Thursday
07:58pm, Thursday, 19'th Feb 2026
It was the subject of a bullish analyst update. In that note, pundit Adam Hotchkiss reiterated his buy recommendation and lofty price target.
Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)
01:44pm, Wednesday, 18'th Feb 2026
I believe Vertex Pharmaceuticals Incorporated's bull run has come to an end. There's a divergence between its stock price growth over the past 5 months and the performance of Journavx and the cystic f
Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash
04:15am, Wednesday, 18'th Feb 2026
Vertex Pharmaceuticals is the leader in cystic fibrosis treatment. The company has also expanded into other areas in recent years, winning approval for two new drugs.
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
04:00pm, Tuesday, 17'th Feb 2026
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in TD Cowen's 46th Annual Health Care Conference. Reshma Kewalramani, President and
Vertex, Inc. (NASDAQ:VERX) Receives Average Recommendation of “Hold” from Brokerages
01:43am, Saturday, 14'th Feb 2026
Shares of Vertex, Inc. (NASDAQ: VERX - Get Free Report) have been given a consensus recommendation of "Hold" by the seventeen ratings firms that are currently covering the stock, MarketBeat reports. O
Vertex Pharma forecasts 2026 revenue in-line, expects growth in cystic fibrosis treatments
04:06pm, Thursday, 12'th Feb 2026
Vertex Pharmaceuticals forecast 2026 revenue largely in line with analysts estimates on Thursday, as the drugmaker bets on growth for its cystic fibrosis treatments as well as contributions from newer
These 5 Software Stocks Could Double in Price This Year, Says Morgan Stanley
03:40pm, Wednesday, 11'th Feb 2026
Software stocks may be down, but they're not out, according to analysts at Morgan Stanley.
Vertex, Inc. (VERX) Q4 2025 Earnings Call Transcript
02:14pm, Wednesday, 11'th Feb 2026
Vertex, Inc. (VERX) Q4 2025 Earnings Call Transcript
Vertex: Buy At Ultracheap Multiples, Product Is Safe From AI
11:23am, Wednesday, 11'th Feb 2026
Vertex has lost ~70% of its value despite steady growth and margin expansion, creating a compelling buy opportunity. VERX's FY26 guidance targets 10%-11% revenue growth and 23% adjusted EBITDA margin,
Compared to Estimates, Vertex (VERX) Q4 Earnings: A Look at Key Metrics
10:31am, Wednesday, 11'th Feb 2026
Although the revenue and EPS for Vertex (VERX) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stree
